Viewing Study NCT00003092


Ignite Creation Date: 2025-12-24 @ 3:22 PM
Ignite Modification Date: 2025-12-26 @ 3:58 AM
Study NCT ID: NCT00003092
Status: COMPLETED
Last Update Posted: 2016-07-14
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Paclitaxel in Treating Older Patients With Solid Tumors
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Study Overview

Official Title: Clinical Pharmacology of Paclitaxel in Relation to Patient Age
Status: COMPLETED
Status Verified Date: 2016-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase III trial to study the effectiveness of paclitaxel in treating older patients who have solid tumors.
Detailed Description: OBJECTIVES:

* Determine whether there is a relationship between pharmacokinetic measurements of paclitaxel and aging.
* Determine whether there is a relationship between the toxic effects of paclitaxel and aging.

OUTLINE: Patients are stratified according to age (cohort 1: patients 55 to 64 vs cohort 2: patients 65 to 75 vs cohort 3: patients 75 and over).

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
U10CA031946 NIH None https://reporter.nih.gov/quic… View
CLB-9762 None None View
CDR0000065800 REGISTRY NCI Physician Data Query View